• Meropenem trihydrate: Reliable Solutions for Resistance Stud

  2026-07-29

  This article provides laboratory scientists with scenario-driven guidance on deploying Meropenem trihydrate (SKU B1217) for reproducible antibiotic resistance studies, infection modeling, and cell-based assays. Drawing from current literature and validated protocols, it highlights key advantages in experimental reliability, solubility, and compatibility for advanced research applications.

• Cy5 NHS ester(Et): Technical Guide for Fluorescent Protein L

  2026-07-29

  Cy5 NHS ester(Et) is a water-soluble fluorescent dye for labeling primary amines in proteins, peptides, and other biomolecules, supporting applications in immunofluorescence staining, flow cytometry, and fluorescence microscopy. It is unsuitable for ethanol-based protocols or workflows requiring long-term storage of dye solutions, necessitating strict handling and prompt use for reproducible results.

• Transmission of Carbapenemase Genes in CREC During COVID-19

  2026-07-28

  Chen et al. (2025) provide a comprehensive molecular and epidemiological analysis of carbapenem-resistant Enterobacter cloacae (CREC) in eight Guangdong hospitals, revealing the high prevalence and efficient transfer of carbapenemase-encoding genes, particularly blaNDM-1. These findings inform multidrug resistance surveillance and underscore the complexity of infection control during the COVID-19 pandemic.

• Ceftazidime in Gram-Negative Resistance: Mechanisms and Rese

  2026-07-28

  Explore how ceftazidime, a third-generation cephalosporin, advances Gram-negative bacterial infection research by targeting β-lactamase-producing strains. This article delivers new scientific perspectives on resistance dynamics, protocol optimization, and translational applications.

• Topotecan for Ovarian Cancer: Systematic Review of Efficacy

  2026-07-27

  This systematic review critically evaluates Topotecan’s clinical efficacy and safety in ovarian cancer, focusing on its use in first-line and recurrent disease settings. The findings contextualize Topotecan’s antitumor activity, its integration into combination regimens, and practical considerations for cancer research workflows.

• Flubendazole in Autophagy Modulation: Protocols & Bench Insi

  2026-07-27

  Flubendazole’s robust DMSO solubility and proven specificity for autophagy make it an indispensable tool for dissecting degradation pathways in cancer and neurodegenerative disease research. This guide delivers actionable protocols, troubleshooting expertise, and workflow integrations to maximize experimental reproducibility and translational relevance.

• Ceftazidime: Third-Generation Cephalosporin for Gram-Negativ

  2026-07-26

  Ceftazidime is a third-generation cephalosporin antibiotic with strong in vitro efficacy against Gram-negative bacteria, notably Pseudomonas aeruginosa. Its robust β-lactamase resistance and clinical utility in pneumonia and bronchitis research distinguish it from other cephalosporins.

• Transmission and Genomics of Carbapenemase Genes in CREC, Gu

  2026-07-25

  This study provides a comprehensive molecular epidemiology of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) collected from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The work highlights key resistance mechanisms, gene mobility, and the clinical and methodological challenges posed by multidrug-resistant CREC, offering critical insights for antibiotic resistance research and surveillance.

• Transmission Dynamics of Carbapenemase Genes in CREC During

  2026-07-24

  Chen et al. provide a detailed molecular epidemiology of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight Guangdong hospitals. The study reveals high rates of multidrug resistance, efficient horizontal gene transfer, and identifies key risk demographics, informing future Gram-negative infection research and clinical surveillance.

• Ozone Enhances Macrophage Efferocytosis to Alleviate Neuropa

  2026-07-24

  This study identifies ozone as an effective modulator of macrophage efferocytosis, alleviating neuropathic pain in mice via activation of the AMPK/Gas6-MerTK/SOCS3 signaling pathway. These mechanistic insights offer new directions for therapeutic strategies targeting neuroinflammation and apoptotic cell clearance.

• Tacrine Hydrochloride Hydrate: Translational Leverage in Alz

  2026-07-23

  This thought-leadership article for translational researchers explores the mechanistic and strategic advantages of Tacrine hydrochloride hydrate (Tetrahydroaminacrine) in Alzheimer's disease research. It integrates recent literature, competitive context, protocol optimization, and a visionary outlook, emphasizing APExBIO's product excellence and scientific leadership.

• HDAC Inhibition Reverses EBV-Induced Plasticity in NPC Cells

  2026-07-23

  A recent study reveals that Epstein-Barr virus (EBV) induces dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma (NPC) via LMP1-mediated epigenetic repression of CEBPA. Importantly, the work demonstrates that HDAC inhibition can restore differentiation and reduce tumorigenic potential, suggesting a new therapeutic strategy for poorly differentiated solid tumors.

• Ceftazidime in Complex Resistance: Precision, Pitfalls, and

  2026-07-22

  Explore the advanced role of Ceftazidime, a third-generation cephalosporin, in modeling Gram-negative bacterial resistance, with unique insight into carbapenemase gene dynamics and practical assay protocols for infection research.

• Pharmacokinetic Variability of CSBTA in MASH Mouse Models

  2026-07-22

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetic properties and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. The findings highlight the impact of disease state and dosing regimen on systemic and hepatic exposure, providing critical guidance for rational dosing in MASLD/MASH research and therapy.

• NOTCH3 R545C Mutation Drives Vascular and Cognitive Deficits

  2026-07-21

  This study introduces a CRISPR/Cas9 mouse model carrying the NOTCH3 R545C mutation, mirroring the prevalent human R544C variant in East Asian CADASIL patients. The research uncovers how this mutation induces vascular degeneration, blood-brain barrier disruption, and cognitive deficits, providing mechanistic insight and a valuable platform for future therapeutic investigations.

16440 records 1/1096 page Next 12345 下5页 Last page